Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma
dc.contributor.author | Piñero, Federico | |
dc.contributor.author | Mendizabal, Manuel | |
dc.contributor.author | Ridruejo, Ezequiel | |
dc.contributor.author | Herz Wolff, Fernando | |
dc.contributor.author | Ameigeiras, Beatriz | |
dc.contributor.author | Anders, Margarita | |
dc.contributor.author | Schinoni, María Isabel | |
dc.contributor.author | Reggiardo, María Virginia | |
dc.contributor.author | Palazzo, Ana | |
dc.contributor.author | Soza, Alejandro | |
dc.contributor.author | Videla, María | |
dc.contributor.author | Alonso, Cristina | |
dc.contributor.author | Santos, Luisa | |
dc.contributor.author | Varón, Adriana | |
dc.contributor.author | Figueroa, Sebastián | |
dc.contributor.author | Vistarini, Cecilia | |
dc.contributor.author | Adrover, Raúl | |
dc.contributor.author | Fernández, Nora | |
dc.contributor.author | Perez, Daniela | |
dc.contributor.author | Tanno, Federico | |
dc.contributor.author | Hernández, Nelia | |
dc.contributor.author | Sixto, Marcela | |
dc.contributor.author | Borzi, Silvia | |
dc.contributor.author | Bruno, Andres | |
dc.contributor.author | Cocozzella, Daniel | |
dc.contributor.author | Descalzi, Valeria | |
dc.contributor.author | Estepo, Claudio | |
dc.contributor.author | Zerega, Alina | |
dc.contributor.author | Araujo, Alexandre de | |
dc.contributor.author | Cheinquer, Hugo | |
dc.contributor.author | Silva, Marcelo | |
dc.contributor.author | LALREAN | |
dc.date.accessioned | 2020-09-04T16:33:34Z | |
dc.date.available | 2020-09-04T16:33:34Z | |
dc.date.issued | 2019 | |
dc.date.updated | 2020-08-18T22:54:51Z | |
dc.fuente.origen | ORCID | |
dc.identifier.doi | 10.1111/liv.14041 | |
dc.identifier.issn | 1478-3231 | |
dc.identifier.uri | https://doi.org/10.1111/liv.14041 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/43789 | |
dc.issue.numero | No. 6 | |
dc.language.iso | en | |
dc.pagina.final | 1043 | |
dc.pagina.inicio | 1033 | |
dc.relation.isformatof | Liver International, vol. 39, no. 6 (Jun. 2019), pp. 1033-1043 | |
dc.revista | Liver International | es_ES |
dc.rights | acceso restringido | |
dc.subject | Direct‐acting antivirals | es_ES |
dc.subject | Eradication | es_ES |
dc.subject | Hepatitis C | es_ES |
dc.subject | Liver cancer | es_ES |
dc.subject | Treatment | es_ES |
dc.subject.ddc | 616.3623 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.title | Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 39 | |
sipa.codpersvinculados | 461 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Treatment with direct‐acting antivirals for HCV decreases.pdf
- Size:
- 111.18 KB
- Format:
- Adobe Portable Document Format
- Description: